Research Paper
Open Access
Infralow neurofeedback in the treatment of substance use disorders: a randomized controlled trial
Karin Berle Gabrielsen, Thomas Clausen, Siri Håvås Haugland, Stig Arvid Hollup and John-Kåre Vederhus
J Psychiatry Neurosci June 15, 2022 47 (3) E222-E229; DOI: https://doi.org/10.1503/jpn.210202
Karin Berle Gabrielsen
From the Addiction Unit, Sørlandet Hospital, Kristiansand, Norway (Gabrielsen, Clausen, Vederhus); the Norwegian Centre for Addiction Research (SERAF), University of Oslo, Oslo, Norway (Clausen); the Department of Psychosocial Health, University of Agder, Grimstad, Norway (Haugland); the Norwegian University of Science and Technology, Trondheim, Norway (Hollup)
MScThomas Clausen
From the Addiction Unit, Sørlandet Hospital, Kristiansand, Norway (Gabrielsen, Clausen, Vederhus); the Norwegian Centre for Addiction Research (SERAF), University of Oslo, Oslo, Norway (Clausen); the Department of Psychosocial Health, University of Agder, Grimstad, Norway (Haugland); the Norwegian University of Science and Technology, Trondheim, Norway (Hollup)
PhDSiri Håvås Haugland
From the Addiction Unit, Sørlandet Hospital, Kristiansand, Norway (Gabrielsen, Clausen, Vederhus); the Norwegian Centre for Addiction Research (SERAF), University of Oslo, Oslo, Norway (Clausen); the Department of Psychosocial Health, University of Agder, Grimstad, Norway (Haugland); the Norwegian University of Science and Technology, Trondheim, Norway (Hollup)
PhDStig Arvid Hollup
From the Addiction Unit, Sørlandet Hospital, Kristiansand, Norway (Gabrielsen, Clausen, Vederhus); the Norwegian Centre for Addiction Research (SERAF), University of Oslo, Oslo, Norway (Clausen); the Department of Psychosocial Health, University of Agder, Grimstad, Norway (Haugland); the Norwegian University of Science and Technology, Trondheim, Norway (Hollup)
MScJohn-Kåre Vederhus
From the Addiction Unit, Sørlandet Hospital, Kristiansand, Norway (Gabrielsen, Clausen, Vederhus); the Norwegian Centre for Addiction Research (SERAF), University of Oslo, Oslo, Norway (Clausen); the Department of Psychosocial Health, University of Agder, Grimstad, Norway (Haugland); the Norwegian University of Science and Technology, Trondheim, Norway (Hollup)
PhD
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Infralow neurofeedback in the treatment of substance use disorders: a randomized controlled trial
Karin Berle Gabrielsen, Thomas Clausen, Siri Håvås Haugland, Stig Arvid Hollup, John-Kåre Vederhus
J Psychiatry Neurosci Jun 2022, 47 (3) E222-E229; DOI: 10.1503/jpn.210202
Related Articles
Cited By...
- No citing articles found.